|
WO2021061904A1
|
|
Collection and separation systems and methods of use thereof and isotope analysis systems and methods of use thereof
|
|
US2021084904A1
|
|
Succinate dehydrogenase inhibitors and sulfur-containing compounds mixtures and methods of use thereof
|
|
US2020398316A1
|
|
Peanut maturity grading systems and methods
|
|
US2021061817A1
|
|
Nitric oxide-releasing antibiotics, methods of making, and methods of use
|
|
US2021039089A1
|
|
Devices, kits, and methods for label-free separation and subtyping of rare cells
|
|
US2021018499A1
|
|
Devices, kits, and methods for label-free focusing and/or separation of sub-micron particles
|
|
WO2020263943A1
|
|
Dual drug antibody-drug conjugates
|
|
US2020397341A1
|
|
Systems and methods of use thereof for determining aerosol particle characteristics
|
|
WO2020236974A1
|
|
Antibodies that bind human metapneumovirus fusion protein and their use
|
|
USPP32817P2
|
|
Abelia plant named ‘00-BC-46-4’
|
|
USPP32818P2
|
|
Abelia plant named 99-6-7
|
|
WO2020223355A1
|
|
Nickel chelation therapy
|
|
WO2020210296A1
|
|
Flow-based microfluidic platform promoting endothelialization
|
|
WO2020206072A1
|
|
Delivery of crispr/mcas9 through extracellular vesicles for genome editing
|
|
WO2020198626A1
|
|
Methods of making targeted vesicles, and compositions made thereby
|
|
WO2020176867A1
|
|
Reactive electrochemical membrane system and methods of making and using
|
|
WO2020176507A1
|
|
Antibacterial wound treatments with clot-promoting properties
|
|
WO2020163611A1
|
|
Indoor occupancy estimation, trajectory tracking and event monitoring and tracking system
|
|
WO2020160351A1
|
|
Contactless monitoring of sleep activities and body vital signs via seismic sensing
|
|
WO2020150623A1
|
|
Salt nanoparticles and compositions and methods of use thereof
|
